An investment bank based out of the United States has cautioned investors that it is shortly going to stop permitting the selling of marijuana corporations functioning in the US.

The New York Mellon bank also released a memo to the investors on November 30, Monday, stating that any arriving positions as well as cannabis stock trading taking part within the markets of the US will be halted.

This fresh authorization applies only to firms with resources of marijuana in the country. The financial institution said that Canadian firms operating without American operations and distribution do not infringe on the act of federal Controlled Substances.

The sale of marijuana is booming already. A recent article by Cryptomoonpress, says that the sale in 2018 worldwide, corresponding to the weed trade, expanded to $10.9 billion, three times more than the last four years.

The bank said that through time and developments, it would take note of the reviews on that “were subject to an order, transaction or incoming transfer to ensure compliance due to federal laws and regulations.”

BNY suggested that banning the trading of marijuana stocks is associated with the drugs federal illicit in the US. Although, Cannabis retains its position as a drug in Schedule I for the federal government, in spite of the programs for legalization observed at the level of the state.

To date, 11 regions, as well as the Columbia District, have legalized marijuana, for medical and recreational practice. Further, 22 states sanction the use of drugs in products of medical cannabis.

BNY Mellon continues to monitor trends in CRB (cannabis-related business) transactions and may impose additional restrictions or require additional information in the future,

the bank said in its note.

The bank requested investors to delay the trading or transaction of the disallowed securities. BNY Mellon warned in the notice:

Through this period, till November 30th, the active date, we encourage you to not trade or transfer in any non-permitted CRB securities, and BNY Mellon’s Pershing reserves the right to reject any non-permitted CRB trades or deposits. After November 30, BNY Mellon’s Pershing will no longer accept any non-permitted CRB trades or deposits.

In the month of September, US cannabis commerce obtained reassurance while the approval from the House of Representatives came through in accordance with Act of Secure and Fair Enforcement Banking in 2019, also known by the name, SAFE Banking.

The bill attempts to build protections to banks as well as additional financial organizations that are in to give banking assistance to cannabis as well as hemp firms in the United States.

The act of  SAFE Banking is headed to Senate now, and here it will probably confront an upward surge to be authorized, say the experts.

The industry is hanging onto the hope that this would make it a lot easier for a lot of these bigger plays to growing a lot quicker, capture market share and bring over the black market to legal channels,

said Nawan Butt, associate portfolio manager of Purpose Investments in a news report.

No matter how you slice the data, marijuana is expected to be one of the fastest-growing industries over the next decade.